These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31762801)

  • 1. Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer.
    Carneiro I; Quintela-Vieira F; Lobo J; Moreira-Barbosa C; Menezes FD; Martins AT; Oliveira J; Silva R; Jerónimo C; Henrique R
    J Cancer; 2019; 10(24):5915-5925. PubMed ID: 31762801
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer.
    Peng W; Feng H; Pang L; Zhang J; Hao Y; Wei X; Xia Q; Wei Z; Song W; Wang S; Liu J; Chen K; Wang T
    J Oncol; 2023; 2023():4539045. PubMed ID: 36755811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
    Cheaito KA; Bahmad HF; Hadadeh O; Saleh E; Dagher C; Hammoud MS; Shahait M; Mrad ZA; Nassif S; Tawil A; Bulbul M; Khauli R; Wazzan W; Nasr R; Shamseddine A; Temraz S; El-Sabban ME; El-Hajj A; Mukherji D; Abou-Kheir W
    Front Oncol; 2019; 9():131. PubMed ID: 30915272
    [No Abstract]   [Full Text] [Related]  

  • 5. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
    Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
    Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
    Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
    Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
    Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
    Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
    Liu CH; Tang WC; Sia P; Huang CC; Yang PM; Wu MH; Lai IL; Lee KH
    Int J Med Sci; 2015; 12(1):63-71. PubMed ID: 25552920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
    Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.
    Alinezhad S; Väänänen RM; Tallgrén T; Perez IM; Jambor I; Aronen H; Kähkönen E; Ettala O; Syvänen K; Nees M; Kallajoki M; Taimen P; Boström PJ; Pettersson K
    Urol Oncol; 2016 Jun; 34(6):255.e15-22. PubMed ID: 26857646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
    Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of WNT5A on epithelial-mesenchymal transition and its correlation with tumor invasion and metastasis in nasopharyngeal carcinoma.
    Zhu HH; Zhu XY; Zhou MH; Cheng GY; Lou WH
    Asian Pac J Trop Med; 2014 Jun; 7(6):488-91. PubMed ID: 25066400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.